Patients with type 2 diabetes may be trained as outpatients to use CSII and have indicated that they prefer CSII to injections, suggesting that pump therapy should be considered when initiating intensive insulin therapy for type 2 diabetes (20,21). The gene discussed is INS; the disease is type 2 diabetes mellitus.